Placebos and nocebos in headaches. (2019)

• Record Type: Book
• Further Information: Note: Dimos D. Mitsikostas, Fabrizio Benedetti, editors.
• Editors: Mitsikostas, Dimos D; Benedetti, F (Fabrizio)
• Contents: Intro; Foreword; Preface; Contents; Chapter 1: Patient-Centred Care in Headaches; 1.1 Introduction; 1.2 The Attempt of a Definition of Patient-Centred Care (PCC); 1.3 The Importance of Recognizing Patients' Health Problems as They See Them as Headache Patients; 1.4 General Aspects of PCC; 1.5 PCC in Headaches; 1.6 Nocebo in PCC; 1.7 Placebo in PCC; 1.8 Successful Headache Management; 1.9 Conclusion; References; Chapter 2: Unmet Needs in Headache Management; 2.1 Acute Treatment in Migraine; 2.2 Preventive Treatment in Migraine; 2.3 Physician-Patient Communication: Treatment Decision-Making 2.4 Patients' Expectations: What Migraineurs Want2.5 Barriers in Episodic Migraine Management; 2.6 Barriers in Chronic Migraine Management; 2.7 Treatment Optimization and Progression from EM to CM; 2.8 Acute Migraine Treatment: Triptans; 2.9 Triptan Discontinuation; 2.10 How to Improve the Efficacy of Triptans; 2.10.1 Response Predictors; 2.10.2 Choice of the First-Line Therapy; 2.10.3 Time to Treatment; 2.10.4 Switching Acute Treatment; 2.10.5 Adding Additional Acute Treatments to Current Triptan Therapy; 2.11 Unmet Needs in EM Patients; 2.12 Unmet Needs in CM Patients 2.13 Placebo and Nocebo Effects in Headache ManagementReferences; Chapter 3: Mechanisms of Pain and Headache; 3.1 Introduction; 3.2 Functional and Molecular Neuroplasticity in Chronic Pain; 3.3 Functional and Structural Neuroplasticity in Headaches and Migraine; 3.4 Molecular and Neuroplasticity and Metabolic Changes in Headaches and Migraine; 3.5 Concluding Remarks; References; Chapter 4: Mechanisms of Placebo and Nocebo; 4.1 Introduction; 4.2 Psychological Mechanisms; 4.3 Neuroanatomical and Neurochemical Underpinnings; 4.4 Clinical Implications; 4.5 Conclusions; References Chapter 5: The Special Case of High-Altitude Headache5.1 High-Altitude Headache: Causes and Pathophysiology; 5.2 The High-Altitude Model; 5.3 Can Placebos and Nocebos Affect Headache at High Altitude?; 5.4 Conclusions; References; Chapter 6: Placebo Response in Human Models of Headache; 6.1 Introduction; 6.2 The Rationale for Using Human Experimental Migraine Studies; 6.3 Placebo Response in Human Experimental Models; 6.4 Placebo in Relation to Vascular Effects in Human Experimental Studies; 6.5 Prevention of Experimentally Induced Headache and Migraine 6.6 Can the Placebo Response Be Mitigated?6.7 Conclusion and Implications for Study Design; References; Chapter 7: Nocebo in Headache Treatment; 7.1 Introduction; 7.2 Methodology to Estimate Nocebos in RCTs for Primary Headaches; 7.3 Nocebos in RCTs for Primary Headaches; 7.4 Q-No Questionnaire; 7.5 Nocebos in Headache Outpatient Sufferers; 7.6 Factors Influencing Nocebos in Headaches; 7.7 Management of Nocebos in Clinical Practice; 7.8 Conclusions; References; Chapter 8: Placebos and Nocebos in Migraine: Children and Adolescents; 8.1 Introduction; 8.2 Pediatric Migraine
• Publisher Details: Cham, Switzerland : Springer
• Publication Date: 2019
• Extent: 1 online resource (ix, 142 pages), illustrations (some color)
• Subjects: 616.8/491; Headache -- Treatment; Placebos (Medicine); Electronic books; Electronic books
• Languages: English
• ISBNs: 9783030029760
• Related ISBNs: 303002976X; 9783030029753
• Notes: Note: Online resource; title from PDF title page (SpringerLink, viewed February 21, 2019).
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.